Alliance Pharma PLC has received a notification of major holdings from Kempen Capital Management N.V. The notification states that Kempen Capital Management N.V. acquired voting rights in Alliance Pharma PLC on November 6, 2023. The total positions of Kempen Capital Management N.V. in terms of voting rights are as follows: 10.189070% of voting rights attached to shares and 0.000000% of voting rights through financial instruments, resulting in a total of 10.189070% of voting rights. Kempen Capital Management N.V. holds a total of 55,157,348 voting rights in Alliance Pharma PLC.
The breakdown of voting rights held by Kempen Capital Management N.V. is as follows: 6,651,289 direct voting rights and 48,506,059 indirect voting rights, representing 1.212390% and 8.976680% of direct and indirect voting rights, respectively. There are no details provided regarding financial instruments that may be exercised or converted to acquire voting rights.
Kempen Capital Management N.V. is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in Alliance Pharma PLC. No information is provided regarding proxy voting.
The notification does not contain any additional information, and it was completed on November 8, 2023. The place of completion is Euroland.com.